ArticlesRegulatory July 29, 2021 Novavax Reports on Two Vaccine Efficacy Studies Novavax’s COVID-19 vaccine is 90.4% effective and maintains efficacy when administered with an... admin-element
ArticlesBioPharmaRegulatory March 26, 2020 Can Vaccine Development Be Safely Accelerated? Human coronaviruses (HCoVs) in the past were considered to cause nothing more than the... admin-element